{"id":362256,"date":"2025-08-31T07:31:00","date_gmt":"2025-08-31T07:31:00","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-innoviva\/"},"modified":"2025-08-31T07:31:00","modified_gmt":"2025-08-31T07:31:00","slug":"how-to-buy-innoviva","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334027,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-362256","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Innoviva, Inc. (INVA) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Innoviva, Inc. (INVA)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Innoviva, Inc. (INVA) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Innoviva, Inc. (INVA)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, d\u1ef1 b\u00e1o 2025-2030 v\u00e0 quy tr\u00ecnh mua t\u1eebng b\u01b0\u1edbc cho c\u01a1 h\u1ed9i trong ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, d\u1ef1 b\u00e1o 2025-2030 v\u00e0 quy tr\u00ecnh mua t\u1eebng b\u01b0\u1edbc cho c\u01a1 h\u1ed9i trong ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c khai th\u00e1c ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m \u0111ang b\u00f9ng n\u1ed5? Innoviva, Inc. (m\u00e3 ch\u1ee9ng kho\u00e1n: INVA) cung c\u1ea5p s\u1ef1 k\u1ebft h\u1ee3p \u0111\u1ed9c \u0111\u00e1o gi\u1eefa s\u1ef1 \u1ed5n \u0111\u1ecbnh doanh thu b\u1ea3n quy\u1ec1n v\u00e0 ph\u00e1t tri\u1ec3n thu\u1ed1c ti\u00ean ti\u1ebfn\u2014ho\u00e0n h\u1ea3o cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm t\u0103ng tr\u01b0\u1edfng v\u1edbi bi\u1ebfn \u0111\u1ed9ng gi\u1ea3m thi\u1ec3u. Vi\u00ean ng\u1ecdc c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u00e0y k\u1ebft h\u1ee3p d\u00f2ng ti\u1ec1n \u1ed5n \u0111\u1ecbnh v\u1edbi ti\u1ec1m n\u0103ng pipeline \u0111\u1ea7y h\u1ee9a h\u1eb9n. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao INVA x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch bi\u1ebfn n\u00f3 th\u00e0nh m\u1ed9t ph\u1ea7n trong h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c khai th\u00e1c ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m \u0111ang b\u00f9ng n\u1ed5? Innoviva, Inc. (m\u00e3 ch\u1ee9ng kho\u00e1n: INVA) cung c\u1ea5p s\u1ef1 k\u1ebft h\u1ee3p \u0111\u1ed9c \u0111\u00e1o gi\u1eefa s\u1ef1 \u1ed5n \u0111\u1ecbnh doanh thu b\u1ea3n quy\u1ec1n v\u00e0 ph\u00e1t tri\u1ec3n thu\u1ed1c ti\u00ean ti\u1ebfn\u2014ho\u00e0n h\u1ea3o cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm t\u0103ng tr\u01b0\u1edfng v\u1edbi bi\u1ebfn \u0111\u1ed9ng gi\u1ea3m thi\u1ec3u. Vi\u00ean ng\u1ecdc c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u00e0y k\u1ebft h\u1ee3p d\u00f2ng ti\u1ec1n \u1ed5n \u0111\u1ecbnh v\u1edbi ti\u1ec1m n\u0103ng pipeline \u0111\u1ea7y h\u1ee9a h\u1eb9n. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao INVA x\u1ee9ng \u0111\u00e1ng \u0111\u01b0\u1ee3c ch\u00fa \u00fd v\u00e0 c\u00e1ch bi\u1ebfn n\u00f3 th\u00e0nh m\u1ed9t ph\u1ea7n trong h\u00e0nh tr\u00ecnh \u0111\u1ea7u t\u01b0 c\u1ee7a b\u1ea1n."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Innoviva: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 31 th\u00e1ng 8 n\u0103m 2025, Innoviva, Inc. (INVA) giao d\u1ecbch \u1edf m\u1ee9c <strong>18,55 USD<\/strong> tr\u00ean s\u00e0n NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>Ng\u00e0y 5 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng\u2014\u0111\u00f3 l\u00e0 khi Innoviva c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng c\u00f3 t\u00e1c \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3.<\/p> <h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng L\u1ee3i Nhu\u1eadn: Tin T\u1ee9c Di Chuy\u1ec3n C\u1ed5 Phi\u1ebfu INVA Nh\u01b0 Th\u1ebf N\u00e0o<\/h3> <p>C\u1ed5 phi\u1ebfu Innoviva \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 nh\u1ea1y c\u1ea3m \u0111\u00e1ng k\u1ec3 v\u1edbi c\u00e1c th\u00f4ng b\u00e1o l\u1ee3i nhu\u1eadn v\u00e0 c\u00e1c di\u1ec5n bi\u1ebfn ph\u00e1p l\u00fd. K\u1ebft qu\u1ea3 qu\u00fd 2 n\u0103m 2025 c\u00f4ng b\u1ed1 ng\u00e0y 6 th\u00e1ng 8 v\u1eeba qua \u0111\u00e3 minh ch\u1ee9ng \u0111i\u1ec1u n\u00e0y\u2014v\u01b0\u1ee3t k\u1ef3 v\u1ecdng c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u1edbi EPS l\u00e0 0,61 USD so v\u1edbi d\u1ef1 \u0111o\u00e1n 0,57 USD, t\u1ea1o \u0111\u1ed9ng l\u1ef1c t\u00edch c\u1ef1c ngay l\u1eadp t\u1ee9c (<a href=\"https:\/\/www.marketbeat.com\/earnings\/reports\/2025-8-6-innoviva-inc-stock\/\">B\u00e1o c\u00e1o L\u1ee3i Nhu\u1eadn MarketBeat<\/a>).<\/p> <p>D\u01b0\u1edbi \u0111\u00e2y l\u00e0 c\u00e1ch c\u00e1c s\u1ef1 ki\u1ec7n l\u1edbn g\u1ea7n \u0111\u00e2y \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn INVA:<\/p> <table> <thead> <tr> <th>Ng\u00e0y<\/th> <th>S\u1ef1 ki\u1ec7n<\/th> <th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th> <th>Thay \u0110\u1ed5i Sau Tin<\/th> <\/tr> <\/thead> <tbody> <tr> <td>6 th\u00e1ng 8, 2025<\/td> <td>V\u01b0\u1ee3t K\u1ef3 V\u1ecdng L\u1ee3i Nhu\u1eadn Qu\u00fd 2<\/td> <td>17,80 USD<\/td> <td>+4,2% (ng\u00e0y ti\u1ebfp theo)<\/td> <\/tr> <tr> <td>15 th\u00e1ng 5, 2025<\/td> <td>Ti\u1ebfn \u0110\u1ed9 Ra M\u1eaft ZEVTERA<\/td> <td>16,90 USD<\/td> <td>+3,8% (3 ng\u00e0y)<\/td> <\/tr> <tr> <td>10 th\u00e1ng 3, 2025<\/td> <td>T\u0103ng Tr\u01b0\u1edfng Doanh Thu B\u1ea3n Quy\u1ec1n<\/td> <td>16,20 USD<\/td> <td>+2,1% (\u1ed5n \u0111\u1ecbnh)<\/td> <\/tr> <tr> <td>5 th\u00e1ng 2, 2025<\/td> <td>K\u1ebft Qu\u1ea3 Qu\u00fd 4 N\u0103m 2024<\/td> <td>15,80 USD<\/td> <td>+5,7% (v\u01b0\u1ee3t k\u1ef3 v\u1ecdng)<\/td> <\/tr> <tr> <td>8 th\u00e1ng 11, 2024<\/td> <td>M\u1edf R\u1ed9ng Quan H\u1ec7 \u0110\u1ed1i T\u00e1c<\/td> <td>15,20 USD<\/td> <td>+4,6% (chi\u1ebfn l\u01b0\u1ee3c)<\/td> <\/tr> <tr> <td>9 th\u00e1ng 8, 2024<\/td> <td>L\u1ee3i Nhu\u1eadn Qu\u00fd 2 N\u0103m 2024<\/td> <td>14,90 USD<\/td> <td>-3,1% (kh\u00f4ng \u0111\u1ea1t)<\/td> <\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng<\/strong>: C\u00e1c b\u1ea5t ng\u1edd t\u00edch c\u1ef1c v\u1ec1 l\u1ee3i nhu\u1eadn th\u01b0\u1eddng gi\u00fap INVA t\u0103ng 4-6% trong v\u00e0i ng\u00e0y, trong khi c\u00e1c k\u1ebft qu\u1ea3 kh\u00f4ng \u0111\u1ea1t g\u00e2y ra gi\u1ea3m t\u1ea1m th\u1eddi 2-4%. C\u1ed5 phi\u1ebfu th\u01b0\u1eddng h\u1ed3i ph\u1ee5c nh\u1edd n\u1ec1n t\u1ea3ng v\u1eefng ch\u1eafc.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: Th\u00e1ng 1 - Th\u00e1ng 8 N\u0103m 2025<\/h2> <p>C\u1ed5 phi\u1ebfu Innoviva \u0111\u00e3 mang l\u1ea1i m\u1ee9c t\u0103ng \u1ea5n t\u01b0\u1ee3ng <strong>17,8%<\/strong> trong s\u00e1u th\u00e1ng qua:<\/p> <p><strong>Th\u00e1ng 1<\/strong>: 15,75 USD (\u1ed5n \u0111\u1ecbnh sau k\u1ef3 ngh\u1ec9)<br\/> <strong>Th\u00e1ng 3<\/strong>: 16,90 USD (s\u1ee9c m\u1ea1nh doanh thu b\u1ea3n quy\u1ec1n)<br\/> <strong>Th\u00e1ng 5<\/strong>: 17,40 USD (t\u0103ng t\u1ed1c doanh s\u1ed1 s\u1ea3n ph\u1ea9m)<br\/> <strong>Th\u00e1ng 7<\/strong>: 18,20 USD (d\u1ef1 \u0111o\u00e1n l\u1ee3i nhu\u1eadn)<br\/> <strong>Th\u00e1ng 8<\/strong>: 18,55 USD (\u0111\u00e0 sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn)<\/p> <p>T\u1ea1i sao gi\u00e1 t\u0103ng \u0111\u1ec1u? Ba y\u1ebfu t\u1ed1 ch\u00ednh:<\/p> <ol> <li><strong>\u1ed4n \u0110\u1ecbnh Doanh Thu B\u1ea3n Quy\u1ec1n<\/strong>: 61,3 tri\u1ec7u USD t\u1eeb c\u00e1c quan h\u1ec7 \u0111\u1ed1i t\u00e1c v\u1edbi GSK t\u1ea1o n\u1ec1n t\u1ea3ng d\u00f2ng ti\u1ec1n<\/li> <li><strong>T\u0103ng Tr\u01b0\u1edfng Doanh S\u1ed1 S\u1ea3n Ph\u1ea9m<\/strong>: T\u0103ng 52% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc trong l\u0129nh v\u1ef1c \u0111i\u1ec1u tr\u1ecb chuy\u00ean bi\u1ec7t<\/li> <li><strong>Ti\u1ec1m N\u0103ng Pipeline<\/strong>: D\u1ef1 \u0111o\u00e1n quy\u1ebft \u0111\u1ecbnh FDA v\u1ec1 Zoliflodacin<\/li> <\/ol> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p><strong>2025 (Cu\u1ed1i N\u0103m)<\/strong>: M\u1ee9c 22-24 USD (th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i ZEVTERA + kh\u1ea3 n\u0103ng ph\u00ea duy\u1ec7t zoliflodacin) \u2192 <strong>MUA M\u1ea0NH<\/strong><\/p> <p><strong>D\u1ef1 B\u00e1o 2026<\/strong>: 26-30 USD (\u0111\u00f3ng g\u00f3p c\u1ea3 n\u0103m t\u1eeb c\u00e1c s\u1ea3n ph\u1ea9m m\u1edbi + m\u1edf r\u1ed9ng quan h\u1ec7 \u0111\u1ed1i t\u00e1c)<\/p> <p><strong>D\u1ef1 B\u00e1o 2028<\/strong>: 35-42 USD (pipeline tr\u01b0\u1edfng th\u00e0nh + kh\u1ea3 n\u0103ng ch\u1ec9 \u0111\u1ecbnh m\u1edbi cho thu\u1ed1c hi\u1ec7n c\u00f3)<\/p> <p><strong>D\u1ef1 B\u00e1o 2030<\/strong>: 45-55+ USD (d\u1eabn \u0111\u1ea7u th\u1ecb tr\u01b0\u1eddng kh\u00e1ng sinh chuy\u00ean bi\u1ec7t + c\u00f3 th\u1ec3 l\u00e0 m\u1ee5c ti\u00eau mua l\u1ea1i)<\/p> <p><strong>K\u1ebft Lu\u1eadn<\/strong>: Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng d\u00e0i h\u1ea1n xu\u1ea5t s\u1eafc v\u1edbi bi\u1ebfn \u0111\u1ed9ng ng\u1eafn h\u1ea1n c\u00f3 th\u1ec3 ki\u1ec3m so\u00e1t. L\u00fd t\u01b0\u1edfng cho chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1 mua.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n L\u01b0u \u00dd<\/h3> <ul> <li><strong>Kh\u00f4ng Ch\u1eafc Ch\u1eafn Ph\u00ea Duy\u1ec7t FDA<\/strong>: Quy\u1ebft \u0111\u1ecbnh th\u00e1ng 12 n\u0103m 2025 v\u1ec1 zoliflodacin c\u00f3 th\u1ec3 l\u00e0m c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng \u00b120%<\/li> <li><strong>Bi\u1ebfn \u0110\u1ed9ng Th\u1ecb Tr\u01b0\u1eddng<\/strong>: RSI 70,83 cho th\u1ea5y kh\u1ea3 n\u0103ng \u0111i\u1ec1u ch\u1ec9nh ng\u1eafn h\u1ea1n<\/li> <li><strong>T\u1eadp Trung Doanh Thu<\/strong>: Ph\u1ee5 thu\u1ed9c l\u1edbn v\u00e0o thanh to\u00e1n b\u1ea3n quy\u1ec1n t\u1eeb GSK (61% doanh thu qu\u00fd 2)<\/li> <li><strong>Thay \u0110\u1ed5i Quy \u0110\u1ecbnh<\/strong>: Ch\u00ednh s\u00e1ch y t\u1ebf c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn gi\u00e1 v\u00e0 ho\u00e0n tr\u1ea3<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3> <ul> <li><strong>\u0110\u00e0 L\u1ee3i Nhu\u1eadn<\/strong>: Qu\u00fd 2 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng 21% v\u1ec1 EPS<\/li> <li><strong>Ra M\u1eaft S\u1ea3n Ph\u1ea9m<\/strong>: ZEVTERA\u00ae ra m\u1eaft t\u1ea1i M\u1ef9 gi\u1eefa n\u0103m 2025 th\u00fac \u0111\u1ea9y t\u0103ng tr\u01b0\u1edfng<\/li> <li><strong>Xu H\u01b0\u1edbng Ng\u00e0nh<\/strong>: Kh\u1ee7ng ho\u1ea3ng kh\u00e1ng thu\u1ed1c kh\u00e1ng sinh th\u00fac \u0111\u1ea9y nhu c\u1ea7u<\/li> <li><strong>B\u1ea3ng C\u00e2n \u0110\u1ed1i M\u1ea1nh<\/strong>: 319,1 tri\u1ec7u USD ti\u1ec1n m\u1eb7t cung c\u1ea5p s\u1ef1 linh ho\u1ea1t v\u1eadn h\u00e0nh<\/li> <li><strong>T\u1ef1 Tin C\u1ee7a Nh\u00e0 Ph\u00e2n T\u00edch<\/strong>: 100% \u0111\u00e1nh gi\u00e1 mua v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 40,25 USD<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 5-10% danh m\u1ee5c v\u00e0o ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li> <li><strong>Trung B\u00ecnh Gi\u00e1 Mua<\/strong>: \u0110\u1ea7u t\u01b0 s\u1ed1 ti\u1ec1n c\u1ed1 \u0111\u1ecbnh h\u00e0ng th\u00e1ng thay v\u00ec c\u1ed1 g\u1eafng b\u1eaft th\u1eddi \u0111i\u1ec3m th\u1ecb tr\u01b0\u1eddng<\/li> <li><strong>\u0110\u1eb7t C\u1ea3nh B\u00e1o Cho Ng\u00e0y 5 Th\u00e1ng 11<\/strong>: B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn c\u00f3 th\u1ec3 t\u1ea1o \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn n\u1ebfu gi\u00e1 gi\u1ea3m<\/li> <li><strong>Theo D\u00f5i L\u1ecbch FDA<\/strong>: Quy\u1ebft \u0111\u1ecbnh v\u1ec1 zoliflodacin ng\u00e0y 15 th\u00e1ng 12 l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn<\/li> <\/ol> <p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: \"Giao d\u1ecbch INVA gi\u1ed1ng nh\u01b0 li\u1ec7u ph\u00e1p kh\u00e1ng sinh\u2014b\u1ea1n c\u1ea7n li\u1ec1u l\u01b0\u1ee3ng \u0111\u00fang v\u00e0o th\u1eddi \u0111i\u1ec3m \u0111\u00fang. Qu\u00e1 li\u1ec1u ph\u1ea5n kh\u00edch c\u00f3 th\u1ec3 g\u00e2y t\u00e1c d\u1ee5ng ph\u1ee5; thi\u1ebfu li\u1ec1u th\u00ec b\u1ea1n s\u1ebd b\u1ecf l\u1ee1 l\u1ee3i nhu\u1eadn ch\u1ed1ng nhi\u1ec5m tr\u00f9ng!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Innoviva, Inc. (INVA) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr> <th>B\u01b0\u1edbc<\/th> <th>H\u00e0nh \u0110\u1ed9ng<\/th> <th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td> <td>\u0110\u1ea3m b\u1ea3o truy c\u1eadp NASDAQ v\u00e0 c\u1ea5u tr\u00fac hoa h\u1ed3ng th\u1ea5p<\/td> <\/tr> <tr> <td>2<\/td> <td>Ho\u00e0n Th\u00e0nh N\u1ea1p Ti\u1ec1n T\u00e0i Kho\u1ea3n<\/td> <td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n c\u00f3 th\u1ec3 qu\u1ea3n l\u00fd\u2014ngay c\u1ea3 100 USD c\u0169ng \u0111\u01b0\u1ee3c<\/td> <\/tr> <tr> <td>3<\/td> <td>T\u00ecm ki\u1ebfm \"INVA\"<\/td> <td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n ch\u00ednh x\u00e1c \u0111\u1ec3 ch\u00ednh x\u00e1c<\/td> <\/tr> <tr> <td>4<\/td> <td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td> <td>Khuy\u1ebfn ngh\u1ecb l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td> <\/tr> <tr> <td>5<\/td> <td>Xem L\u1ea1i v\u00e0 Th\u1ef1c Hi\u1ec7n<\/td> <td>Ki\u1ec3m tra k\u1ef9 chi ti\u1ebft l\u1ec7nh tr\u01b0\u1edbc khi x\u00e1c nh\u1eadn<\/td> <\/tr> <tr> <td>6<\/td> <td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td> <td>Theo d\u00f5i c\u00e1c m\u1ee9c quan tr\u1ecdng cho quy\u1ebft \u0111\u1ecbnh t\u01b0\u01a1ng lai<\/td> <\/tr> <tr> <td>7<\/td> <td>Ghi L\u1ea1i Lu\u1eadn \u0110i\u1ec3m \u0110\u1ea7u T\u01b0<\/td> <td>Ghi ch\u00fa l\u00fd do \u0111\u1ea7u t\u01b0 \u0111\u1ec3 tham kh\u1ea3o sau n\u00e0y<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>Pocket Option c\u00e1ch m\u1ea1ng h\u00f3a vi\u1ec7c ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong>\u2014th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro t\u1ed1i thi\u1ec3u<\/li> <li><strong>X\u00e1c minh trong 1 ph\u00fat<\/strong>\u2014ch\u1ec9 c\u1ea7n m\u1ed9t t\u00e0i li\u1ec7u \u0111\u1ec3 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong>\u2014t\u1eeb ti\u1ec1n \u0111i\u1ec7n t\u1eed \u0111\u1ebfn chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng<\/li> <li><strong>C\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n c\u00f3 s\u1eb5n<\/strong>\u2014mua ph\u1ea7n nh\u1ecf c\u1ee7a c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n<\/li> <li><strong>D\u1eef li\u1ec7u th\u1ecb tr\u01b0\u1eddng th\u1eddi gian th\u1ef1c<\/strong>\u2014ra quy\u1ebft \u0111\u1ecbnh th\u00f4ng minh kh\u00f4ng b\u1ecb tr\u00ec ho\u00e3n<\/li> <\/ul> <h2>\ud83c\udf0d Innoviva N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi D\u01b0\u1ee3c Ph\u1ea9m<\/h2> <p>Innoviva th\u1ed1ng l\u0129nh l\u0129nh v\u1ef1c d\u01b0\u1ee3c ph\u1ea9m chuy\u00ean bi\u1ec7t v\u1edbi m\u00f4 h\u00ecnh k\u00e9p \u0111\u1ed9c \u0111\u00e1o: thu nh\u1eadp b\u1ea3n quy\u1ec1n \u1ed5n \u0111\u1ecbnh t\u1eeb c\u00e1c thu\u1ed1c h\u00f4 h\u1ea5p \u0111\u00e3 \u0111\u01b0\u1ee3c thi\u1ebft l\u1eadp k\u1ebft h\u1ee3p v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng cao t\u1eeb c\u00e1c thu\u1ed1c ch\u1ed1ng nhi\u1ec5m tr\u00f9ng m\u1edbi. T\u1eadp trung chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a c\u00f4ng ty v\u00e0o vi\u1ec7c gi\u1ea3i quy\u1ebft kh\u00e1ng thu\u1ed1c kh\u00e1ng sinh\u2014m\u1ed9t cu\u1ed9c kh\u1ee7ng ho\u1ea3ng y t\u1ebf to\u00e0n c\u1ea7u \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi m\u1ed7i n\u0103m\u2014\u0111\u1eb7t h\u1ecd v\u00e0o v\u1ecb tr\u00ed ho\u00e0n h\u1ea3o cho th\u00e0nh c\u00f4ng d\u00e0i h\u1ea1n.<\/p> <p>V\u1ecb th\u1ebf th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i: <strong>v\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng 1,3 t\u1ef7 USD<\/strong> v\u1edbi bi\u00ean l\u1ee3i nhu\u1eadn g\u1ed9p m\u1ea1nh 85,94% th\u1ec3 hi\u1ec7n hi\u1ec7u qu\u1ea3 v\u1eadn h\u00e0nh xu\u1ea5t s\u1eafc (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-inva\/innoviva\">Simply Wall St<\/a>).<\/p> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: B\u1ed9 ph\u1eadn \u0111\u1ea7u t\u01b0 c\u1ee7a Innoviva v\u1eeba cung c\u1ea5p kho\u1ea3n t\u00edn d\u1ee5ng 10 tri\u1ec7u USD cho Armata Pharmaceuticals \u0111\u1ec3 ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p phage nh\u1eafm v\u00e0o c\u00e1c nhi\u1ec5m tr\u00f9ng kh\u00e1ng thu\u1ed1c\u2014cho th\u1ea5y cam k\u1ebft c\u1ee7a h\u1ecd trong vi\u1ec7c gi\u1ea3i quy\u1ebft m\u1ed9t trong nh\u1eefng th\u00e1ch th\u1ee9c l\u1edbn nh\u1ea5t c\u1ee7a y h\u1ecdc \u0111\u1ed3ng th\u1eddi t\u1ea1o ra c\u00e1c d\u00f2ng doanh thu ti\u1ec1m n\u0103ng trong t\u01b0\u01a1ng lai.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Innoviva: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 31 th\u00e1ng 8 n\u0103m 2025, Innoviva, Inc. (INVA) giao d\u1ecbch \u1edf m\u1ee9c <strong>18,55 USD<\/strong> tr\u00ean s\u00e0n NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>Ng\u00e0y 5 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng\u2014\u0111\u00f3 l\u00e0 khi Innoviva c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng c\u00f3 t\u00e1c \u0111\u1ed9ng \u0111\u00e1ng k\u1ec3.<\/p>\n<h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng L\u1ee3i Nhu\u1eadn: Tin T\u1ee9c Di Chuy\u1ec3n C\u1ed5 Phi\u1ebfu INVA Nh\u01b0 Th\u1ebf N\u00e0o<\/h3>\n<p>C\u1ed5 phi\u1ebfu Innoviva \u0111\u00e3 th\u1ec3 hi\u1ec7n s\u1ef1 nh\u1ea1y c\u1ea3m \u0111\u00e1ng k\u1ec3 v\u1edbi c\u00e1c th\u00f4ng b\u00e1o l\u1ee3i nhu\u1eadn v\u00e0 c\u00e1c di\u1ec5n bi\u1ebfn ph\u00e1p l\u00fd. K\u1ebft qu\u1ea3 qu\u00fd 2 n\u0103m 2025 c\u00f4ng b\u1ed1 ng\u00e0y 6 th\u00e1ng 8 v\u1eeba qua \u0111\u00e3 minh ch\u1ee9ng \u0111i\u1ec1u n\u00e0y\u2014v\u01b0\u1ee3t k\u1ef3 v\u1ecdng c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch v\u1edbi EPS l\u00e0 0,61 USD so v\u1edbi d\u1ef1 \u0111o\u00e1n 0,57 USD, t\u1ea1o \u0111\u1ed9ng l\u1ef1c t\u00edch c\u1ef1c ngay l\u1eadp t\u1ee9c (<a href=\"https:\/\/www.marketbeat.com\/earnings\/reports\/2025-8-6-innoviva-inc-stock\/\">B\u00e1o c\u00e1o L\u1ee3i Nhu\u1eadn MarketBeat<\/a>).<\/p>\n<p>D\u01b0\u1edbi \u0111\u00e2y l\u00e0 c\u00e1ch c\u00e1c s\u1ef1 ki\u1ec7n l\u1edbn g\u1ea7n \u0111\u00e2y \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn INVA:<\/p>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>6 th\u00e1ng 8, 2025<\/td>\n<td>V\u01b0\u1ee3t K\u1ef3 V\u1ecdng L\u1ee3i Nhu\u1eadn Qu\u00fd 2<\/td>\n<td>17,80 USD<\/td>\n<td>+4,2% (ng\u00e0y ti\u1ebfp theo)<\/td>\n<\/tr>\n<tr>\n<td>15 th\u00e1ng 5, 2025<\/td>\n<td>Ti\u1ebfn \u0110\u1ed9 Ra M\u1eaft ZEVTERA<\/td>\n<td>16,90 USD<\/td>\n<td>+3,8% (3 ng\u00e0y)<\/td>\n<\/tr>\n<tr>\n<td>10 th\u00e1ng 3, 2025<\/td>\n<td>T\u0103ng Tr\u01b0\u1edfng Doanh Thu B\u1ea3n Quy\u1ec1n<\/td>\n<td>16,20 USD<\/td>\n<td>+2,1% (\u1ed5n \u0111\u1ecbnh)<\/td>\n<\/tr>\n<tr>\n<td>5 th\u00e1ng 2, 2025<\/td>\n<td>K\u1ebft Qu\u1ea3 Qu\u00fd 4 N\u0103m 2024<\/td>\n<td>15,80 USD<\/td>\n<td>+5,7% (v\u01b0\u1ee3t k\u1ef3 v\u1ecdng)<\/td>\n<\/tr>\n<tr>\n<td>8 th\u00e1ng 11, 2024<\/td>\n<td>M\u1edf R\u1ed9ng Quan H\u1ec7 \u0110\u1ed1i T\u00e1c<\/td>\n<td>15,20 USD<\/td>\n<td>+4,6% (chi\u1ebfn l\u01b0\u1ee3c)<\/td>\n<\/tr>\n<tr>\n<td>9 th\u00e1ng 8, 2024<\/td>\n<td>L\u1ee3i Nhu\u1eadn Qu\u00fd 2 N\u0103m 2024<\/td>\n<td>14,90 USD<\/td>\n<td>-3,1% (kh\u00f4ng \u0111\u1ea1t)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng<\/strong>: C\u00e1c b\u1ea5t ng\u1edd t\u00edch c\u1ef1c v\u1ec1 l\u1ee3i nhu\u1eadn th\u01b0\u1eddng gi\u00fap INVA t\u0103ng 4-6% trong v\u00e0i ng\u00e0y, trong khi c\u00e1c k\u1ebft qu\u1ea3 kh\u00f4ng \u0111\u1ea1t g\u00e2y ra gi\u1ea3m t\u1ea1m th\u1eddi 2-4%. C\u1ed5 phi\u1ebfu th\u01b0\u1eddng h\u1ed3i ph\u1ee5c nh\u1edd n\u1ec1n t\u1ea3ng v\u1eefng ch\u1eafc.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: Th\u00e1ng 1 &#8211; Th\u00e1ng 8 N\u0103m 2025<\/h2>\n<p>C\u1ed5 phi\u1ebfu Innoviva \u0111\u00e3 mang l\u1ea1i m\u1ee9c t\u0103ng \u1ea5n t\u01b0\u1ee3ng <strong>17,8%<\/strong> trong s\u00e1u th\u00e1ng qua:<\/p>\n<p><strong>Th\u00e1ng 1<\/strong>: 15,75 USD (\u1ed5n \u0111\u1ecbnh sau k\u1ef3 ngh\u1ec9)<br \/> <strong>Th\u00e1ng 3<\/strong>: 16,90 USD (s\u1ee9c m\u1ea1nh doanh thu b\u1ea3n quy\u1ec1n)<br \/> <strong>Th\u00e1ng 5<\/strong>: 17,40 USD (t\u0103ng t\u1ed1c doanh s\u1ed1 s\u1ea3n ph\u1ea9m)<br \/> <strong>Th\u00e1ng 7<\/strong>: 18,20 USD (d\u1ef1 \u0111o\u00e1n l\u1ee3i nhu\u1eadn)<br \/> <strong>Th\u00e1ng 8<\/strong>: 18,55 USD (\u0111\u00e0 sau b\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn)<\/p>\n<p>T\u1ea1i sao gi\u00e1 t\u0103ng \u0111\u1ec1u? Ba y\u1ebfu t\u1ed1 ch\u00ednh:<\/p>\n<ol>\n<li><strong>\u1ed4n \u0110\u1ecbnh Doanh Thu B\u1ea3n Quy\u1ec1n<\/strong>: 61,3 tri\u1ec7u USD t\u1eeb c\u00e1c quan h\u1ec7 \u0111\u1ed1i t\u00e1c v\u1edbi GSK t\u1ea1o n\u1ec1n t\u1ea3ng d\u00f2ng ti\u1ec1n<\/li>\n<li><strong>T\u0103ng Tr\u01b0\u1edfng Doanh S\u1ed1 S\u1ea3n Ph\u1ea9m<\/strong>: T\u0103ng 52% so v\u1edbi c\u00f9ng k\u1ef3 n\u0103m tr\u01b0\u1edbc trong l\u0129nh v\u1ef1c \u0111i\u1ec1u tr\u1ecb chuy\u00ean bi\u1ec7t<\/li>\n<li><strong>Ti\u1ec1m N\u0103ng Pipeline<\/strong>: D\u1ef1 \u0111o\u00e1n quy\u1ebft \u0111\u1ecbnh FDA v\u1ec1 Zoliflodacin<\/li>\n<\/ol>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p><strong>2025 (Cu\u1ed1i N\u0103m)<\/strong>: M\u1ee9c 22-24 USD (th\u00e0nh c\u00f4ng th\u01b0\u01a1ng m\u1ea1i ZEVTERA + kh\u1ea3 n\u0103ng ph\u00ea duy\u1ec7t zoliflodacin) \u2192 <strong>MUA M\u1ea0NH<\/strong><\/p>\n<p><strong>D\u1ef1 B\u00e1o 2026<\/strong>: 26-30 USD (\u0111\u00f3ng g\u00f3p c\u1ea3 n\u0103m t\u1eeb c\u00e1c s\u1ea3n ph\u1ea9m m\u1edbi + m\u1edf r\u1ed9ng quan h\u1ec7 \u0111\u1ed1i t\u00e1c)<\/p>\n<p><strong>D\u1ef1 B\u00e1o 2028<\/strong>: 35-42 USD (pipeline tr\u01b0\u1edfng th\u00e0nh + kh\u1ea3 n\u0103ng ch\u1ec9 \u0111\u1ecbnh m\u1edbi cho thu\u1ed1c hi\u1ec7n c\u00f3)<\/p>\n<p><strong>D\u1ef1 B\u00e1o 2030<\/strong>: 45-55+ USD (d\u1eabn \u0111\u1ea7u th\u1ecb tr\u01b0\u1eddng kh\u00e1ng sinh chuy\u00ean bi\u1ec7t + c\u00f3 th\u1ec3 l\u00e0 m\u1ee5c ti\u00eau mua l\u1ea1i)<\/p>\n<p><strong>K\u1ebft Lu\u1eadn<\/strong>: Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng d\u00e0i h\u1ea1n xu\u1ea5t s\u1eafc v\u1edbi bi\u1ebfn \u0111\u1ed9ng ng\u1eafn h\u1ea1n c\u00f3 th\u1ec3 ki\u1ec3m so\u00e1t. L\u00fd t\u01b0\u1edfng cho chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1 mua.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n L\u01b0u \u00dd<\/h3>\n<ul>\n<li><strong>Kh\u00f4ng Ch\u1eafc Ch\u1eafn Ph\u00ea Duy\u1ec7t FDA<\/strong>: Quy\u1ebft \u0111\u1ecbnh th\u00e1ng 12 n\u0103m 2025 v\u1ec1 zoliflodacin c\u00f3 th\u1ec3 l\u00e0m c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng \u00b120%<\/li>\n<li><strong>Bi\u1ebfn \u0110\u1ed9ng Th\u1ecb Tr\u01b0\u1eddng<\/strong>: RSI 70,83 cho th\u1ea5y kh\u1ea3 n\u0103ng \u0111i\u1ec1u ch\u1ec9nh ng\u1eafn h\u1ea1n<\/li>\n<li><strong>T\u1eadp Trung Doanh Thu<\/strong>: Ph\u1ee5 thu\u1ed9c l\u1edbn v\u00e0o thanh to\u00e1n b\u1ea3n quy\u1ec1n t\u1eeb GSK (61% doanh thu qu\u00fd 2)<\/li>\n<li><strong>Thay \u0110\u1ed5i Quy \u0110\u1ecbnh<\/strong>: Ch\u00ednh s\u00e1ch y t\u1ebf c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn gi\u00e1 v\u00e0 ho\u00e0n tr\u1ea3<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>\u0110\u00e0 L\u1ee3i Nhu\u1eadn<\/strong>: Qu\u00fd 2 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng 21% v\u1ec1 EPS<\/li>\n<li><strong>Ra M\u1eaft S\u1ea3n Ph\u1ea9m<\/strong>: ZEVTERA\u00ae ra m\u1eaft t\u1ea1i M\u1ef9 gi\u1eefa n\u0103m 2025 th\u00fac \u0111\u1ea9y t\u0103ng tr\u01b0\u1edfng<\/li>\n<li><strong>Xu H\u01b0\u1edbng Ng\u00e0nh<\/strong>: Kh\u1ee7ng ho\u1ea3ng kh\u00e1ng thu\u1ed1c kh\u00e1ng sinh th\u00fac \u0111\u1ea9y nhu c\u1ea7u<\/li>\n<li><strong>B\u1ea3ng C\u00e2n \u0110\u1ed1i M\u1ea1nh<\/strong>: 319,1 tri\u1ec7u USD ti\u1ec1n m\u1eb7t cung c\u1ea5p s\u1ef1 linh ho\u1ea1t v\u1eadn h\u00e0nh<\/li>\n<li><strong>T\u1ef1 Tin C\u1ee7a Nh\u00e0 Ph\u00e2n T\u00edch<\/strong>: 100% \u0111\u00e1nh gi\u00e1 mua v\u1edbi m\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 40,25 USD<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 5-10% danh m\u1ee5c v\u00e0o ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li>\n<li><strong>Trung B\u00ecnh Gi\u00e1 Mua<\/strong>: \u0110\u1ea7u t\u01b0 s\u1ed1 ti\u1ec1n c\u1ed1 \u0111\u1ecbnh h\u00e0ng th\u00e1ng thay v\u00ec c\u1ed1 g\u1eafng b\u1eaft th\u1eddi \u0111i\u1ec3m th\u1ecb tr\u01b0\u1eddng<\/li>\n<li><strong>\u0110\u1eb7t C\u1ea3nh B\u00e1o Cho Ng\u00e0y 5 Th\u00e1ng 11<\/strong>: B\u00e1o c\u00e1o l\u1ee3i nhu\u1eadn c\u00f3 th\u1ec3 t\u1ea1o \u0111i\u1ec3m v\u00e0o h\u1ea5p d\u1eabn n\u1ebfu gi\u00e1 gi\u1ea3m<\/li>\n<li><strong>Theo D\u00f5i L\u1ecbch FDA<\/strong>: Quy\u1ebft \u0111\u1ecbnh v\u1ec1 zoliflodacin ng\u00e0y 15 th\u00e1ng 12 l\u00e0 ch\u1ea5t x\u00fac t\u00e1c l\u1edbn<\/li>\n<\/ol>\n<p>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc: &#8220;Giao d\u1ecbch INVA gi\u1ed1ng nh\u01b0 li\u1ec7u ph\u00e1p kh\u00e1ng sinh\u2014b\u1ea1n c\u1ea7n li\u1ec1u l\u01b0\u1ee3ng \u0111\u00fang v\u00e0o th\u1eddi \u0111i\u1ec3m \u0111\u00fang. Qu\u00e1 li\u1ec1u ph\u1ea5n kh\u00edch c\u00f3 th\u1ec3 g\u00e2y t\u00e1c d\u1ee5ng ph\u1ee5; thi\u1ebfu li\u1ec1u th\u00ec b\u1ea1n s\u1ebd b\u1ecf l\u1ee1 l\u1ee3i nhu\u1eadn ch\u1ed1ng nhi\u1ec5m tr\u00f9ng!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Innoviva, Inc. (INVA) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o truy c\u1eadp NASDAQ v\u00e0 c\u1ea5u tr\u00fac hoa h\u1ed3ng th\u1ea5p<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n Th\u00e0nh N\u1ea1p Ti\u1ec1n T\u00e0i Kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n c\u00f3 th\u1ec3 qu\u1ea3n l\u00fd\u2014ngay c\u1ea3 100 USD c\u0169ng \u0111\u01b0\u1ee3c<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;INVA&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n ch\u00ednh x\u00e1c \u0111\u1ec3 ch\u00ednh x\u00e1c<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td>\n<td>Khuy\u1ebfn ngh\u1ecb l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem L\u1ea1i v\u00e0 Th\u1ef1c Hi\u1ec7n<\/td>\n<td>Ki\u1ec3m tra k\u1ef9 chi ti\u1ebft l\u1ec7nh tr\u01b0\u1edbc khi x\u00e1c nh\u1eadn<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td>\n<td>Theo d\u00f5i c\u00e1c m\u1ee9c quan tr\u1ecdng cho quy\u1ebft \u0111\u1ecbnh t\u01b0\u01a1ng lai<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Ghi L\u1ea1i Lu\u1eadn \u0110i\u1ec3m \u0110\u1ea7u T\u01b0<\/td>\n<td>Ghi ch\u00fa l\u00fd do \u0111\u1ea7u t\u01b0 \u0111\u1ec3 tham kh\u1ea3o sau n\u00e0y<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>Pocket Option c\u00e1ch m\u1ea1ng h\u00f3a vi\u1ec7c ti\u1ebfp c\u1eadn c\u1ed5 phi\u1ebfu cho ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong>\u2014th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi r\u1ee7i ro t\u1ed1i thi\u1ec3u<\/li>\n<li><strong>X\u00e1c minh trong 1 ph\u00fat<\/strong>\u2014ch\u1ec9 c\u1ea7n m\u1ed9t t\u00e0i li\u1ec7u \u0111\u1ec3 b\u1eaft \u0111\u1ea7u giao d\u1ecbch ngay<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong>\u2014t\u1eeb ti\u1ec1n \u0111i\u1ec7n t\u1eed \u0111\u1ebfn chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng<\/li>\n<li><strong>C\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n c\u00f3 s\u1eb5n<\/strong>\u2014mua ph\u1ea7n nh\u1ecf c\u1ee7a c\u1ed5 phi\u1ebfu \u0111\u1eaft ti\u1ec1n<\/li>\n<li><strong>D\u1eef li\u1ec7u th\u1ecb tr\u01b0\u1eddng th\u1eddi gian th\u1ef1c<\/strong>\u2014ra quy\u1ebft \u0111\u1ecbnh th\u00f4ng minh kh\u00f4ng b\u1ecb tr\u00ec ho\u00e3n<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Innoviva N\u0103m 2025: Nh\u00e0 L\u00e3nh \u0110\u1ea1o \u0110\u1ed5i M\u1edbi D\u01b0\u1ee3c Ph\u1ea9m<\/h2>\n<p>Innoviva th\u1ed1ng l\u0129nh l\u0129nh v\u1ef1c d\u01b0\u1ee3c ph\u1ea9m chuy\u00ean bi\u1ec7t v\u1edbi m\u00f4 h\u00ecnh k\u00e9p \u0111\u1ed9c \u0111\u00e1o: thu nh\u1eadp b\u1ea3n quy\u1ec1n \u1ed5n \u0111\u1ecbnh t\u1eeb c\u00e1c thu\u1ed1c h\u00f4 h\u1ea5p \u0111\u00e3 \u0111\u01b0\u1ee3c thi\u1ebft l\u1eadp k\u1ebft h\u1ee3p v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng cao t\u1eeb c\u00e1c thu\u1ed1c ch\u1ed1ng nhi\u1ec5m tr\u00f9ng m\u1edbi. T\u1eadp trung chi\u1ebfn l\u01b0\u1ee3c c\u1ee7a c\u00f4ng ty v\u00e0o vi\u1ec7c gi\u1ea3i quy\u1ebft kh\u00e1ng thu\u1ed1c kh\u00e1ng sinh\u2014m\u1ed9t cu\u1ed9c kh\u1ee7ng ho\u1ea3ng y t\u1ebf to\u00e0n c\u1ea7u \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn h\u00e0ng tri\u1ec7u ng\u01b0\u1eddi m\u1ed7i n\u0103m\u2014\u0111\u1eb7t h\u1ecd v\u00e0o v\u1ecb tr\u00ed ho\u00e0n h\u1ea3o cho th\u00e0nh c\u00f4ng d\u00e0i h\u1ea1n.<\/p>\n<p>V\u1ecb th\u1ebf th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i: <strong>v\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng 1,3 t\u1ef7 USD<\/strong> v\u1edbi bi\u00ean l\u1ee3i nhu\u1eadn g\u1ed9p m\u1ea1nh 85,94% th\u1ec3 hi\u1ec7n hi\u1ec7u qu\u1ea3 v\u1eadn h\u00e0nh xu\u1ea5t s\u1eafc (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-inva\/innoviva\">Simply Wall St<\/a>).<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: B\u1ed9 ph\u1eadn \u0111\u1ea7u t\u01b0 c\u1ee7a Innoviva v\u1eeba cung c\u1ea5p kho\u1ea3n t\u00edn d\u1ee5ng 10 tri\u1ec7u USD cho Armata Pharmaceuticals \u0111\u1ec3 ph\u00e1t tri\u1ec3n li\u1ec7u ph\u00e1p phage nh\u1eafm v\u00e0o c\u00e1c nhi\u1ec5m tr\u00f9ng kh\u00e1ng thu\u1ed1c\u2014cho th\u1ea5y cam k\u1ebft c\u1ee7a h\u1ecd trong vi\u1ec7c gi\u1ea3i quy\u1ebft m\u1ed9t trong nh\u1eefng th\u00e1ch th\u1ee9c l\u1edbn nh\u1ea5t c\u1ee7a y h\u1ecdc \u0111\u1ed3ng th\u1eddi t\u1ea1o ra c\u00e1c d\u00f2ng doanh thu ti\u1ec1m n\u0103ng trong t\u01b0\u01a1ng lai.<\/p>\n"},"faq":[{"question":"Innoviva, Inc. (INVA) l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Innoviva, Inc. l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc chuy\u00ean v\u1ec1 ph\u00e1t tri\u1ec3n v\u00e0 th\u01b0\u01a1ng m\u1ea1i h\u00f3a c\u00e1c thu\u1ed1c \u0111i\u1ec1u tr\u1ecb h\u00f4 h\u1ea5p v\u00e0 ch\u1ed1ng nhi\u1ec5m tr\u00f9ng v\u1edbi m\u00f4 h\u00ecnh thu nh\u1eadp d\u1ef1a tr\u00ean b\u1ea3n quy\u1ec1n v\u00e0 ph\u00e1t tri\u1ec3n s\u1ea3n ph\u1ea9m m\u1edbi."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu INVA?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu INVA th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 truy c\u1eadp s\u00e0n NASDAQ, b\u1eb1ng c\u00e1ch t\u00ecm m\u00e3 INVA, ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 th\u1ef1c hi\u1ec7n giao d\u1ecbch theo h\u01b0\u1edbng d\u1eabn t\u1eebng b\u01b0\u1edbc."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o INVA l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m s\u1ef1 kh\u00f4ng ch\u1eafc ch\u1eafn trong ph\u00ea duy\u1ec7t FDA cho s\u1ea3n ph\u1ea9m m\u1edbi, bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng, s\u1ef1 ph\u1ee5 thu\u1ed9c l\u1edbn v\u00e0o doanh thu b\u1ea3n quy\u1ec1n t\u1eeb GSK v\u00e0 c\u00e1c thay \u0111\u1ed5i trong ch\u00ednh s\u00e1ch y t\u1ebf."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu INVA trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o gi\u00e1 INVA \u0111\u1ebfn n\u0103m 2030 c\u00f3 th\u1ec3 \u0111\u1ea1t t\u1eeb 45 \u0111\u1ebfn tr\u00ean 55 USD, v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng m\u1ea1nh nh\u1edd c\u00e1c s\u1ea3n ph\u1ea9m m\u1edbi v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng."},{"question":"T\u1ea1i sao Pocket Option ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n, h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n v\u00e0 cung c\u1ea5p d\u1eef li\u1ec7u th\u1ecb tr\u01b0\u1eddng th\u1eddi gian th\u1ef1c, gi\u00fap nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi d\u1ec5 d\u00e0ng ti\u1ebfp c\u1eadn v\u00e0 giao d\u1ecbch."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Innoviva, Inc. (INVA) l\u00e0 c\u00f4ng ty g\u00ec?","answer":"Innoviva, Inc. l\u00e0 m\u1ed9t c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc chuy\u00ean v\u1ec1 ph\u00e1t tri\u1ec3n v\u00e0 th\u01b0\u01a1ng m\u1ea1i h\u00f3a c\u00e1c thu\u1ed1c \u0111i\u1ec1u tr\u1ecb h\u00f4 h\u1ea5p v\u00e0 ch\u1ed1ng nhi\u1ec5m tr\u00f9ng v\u1edbi m\u00f4 h\u00ecnh thu nh\u1eadp d\u1ef1a tr\u00ean b\u1ea3n quy\u1ec1n v\u00e0 ph\u00e1t tri\u1ec3n s\u1ea3n ph\u1ea9m m\u1edbi."},{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu INVA?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu INVA th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 truy c\u1eadp s\u00e0n NASDAQ, b\u1eb1ng c\u00e1ch t\u00ecm m\u00e3 INVA, ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 th\u1ef1c hi\u1ec7n giao d\u1ecbch theo h\u01b0\u1edbng d\u1eabn t\u1eebng b\u01b0\u1edbc."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o INVA l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh bao g\u1ed3m s\u1ef1 kh\u00f4ng ch\u1eafc ch\u1eafn trong ph\u00ea duy\u1ec7t FDA cho s\u1ea3n ph\u1ea9m m\u1edbi, bi\u1ebfn \u0111\u1ed9ng th\u1ecb tr\u01b0\u1eddng, s\u1ef1 ph\u1ee5 thu\u1ed9c l\u1edbn v\u00e0o doanh thu b\u1ea3n quy\u1ec1n t\u1eeb GSK v\u00e0 c\u00e1c thay \u0111\u1ed5i trong ch\u00ednh s\u00e1ch y t\u1ebf."},{"question":"D\u1ef1 b\u00e1o gi\u00e1 c\u1ed5 phi\u1ebfu INVA trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o gi\u00e1 INVA \u0111\u1ebfn n\u0103m 2030 c\u00f3 th\u1ec3 \u0111\u1ea1t t\u1eeb 45 \u0111\u1ebfn tr\u00ean 55 USD, v\u1edbi ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng m\u1ea1nh nh\u1edd c\u00e1c s\u1ea3n ph\u1ea9m m\u1edbi v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng."},{"question":"T\u1ea1i sao Pocket Option ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, x\u00e1c minh nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n, h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu ph\u00e2n \u0111o\u1ea1n v\u00e0 cung c\u1ea5p d\u1eef li\u1ec7u th\u1ecb tr\u01b0\u1eddng th\u1eddi gian th\u1ef1c, gi\u00fap nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi d\u1ec5 d\u00e0ng ti\u1ebfp c\u1eadn v\u00e0 giao d\u1ecbch."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-31T07:31:00+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA)\",\"datePublished\":\"2025-08-31T07:31:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"datePublished\":\"2025-08-31T07:31:00+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-31T07:31:00+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA)","datePublished":"2025-08-31T07:31:00+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","datePublished":"2025-08-31T07:31:00+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals5.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-innoviva\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Innoviva, Inc. (INVA)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":362260,"slug":"how-to-buy-innoviva","post_title":"Como comprar a\u00e7\u00f5es da Innoviva, Inc. (INVA) - Investimento em a\u00e7\u00f5es da Innoviva, Inc. (INVA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-innoviva\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/362256","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=362256"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/362256\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334027"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=362256"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=362256"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=362256"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}